CRIZALK CAPSULES

CRIZALK CAPSULES Specification

Salt Composition
Crizotinib

Dosage Form
Capsules

Indication
Treatment of non-small cell lung cancer (NSCLC)

Feature
Targeted therapy, oral administration, prescription only

Ingredients
Crizotinib 250mg

Application
Anti-cancer medication for oral use

Physical Color/Texture
Capsule form (exact color not specified)

Storage Instructions
Store in a cool and dry place, away from direct sunlight

Shelf Life
Check packaging for expiry date

Route of Administration
Oral

Language on Pack
English, Hindi

Target Patient Group
Adults with certain types of lung cancer

Strength
250 mg per capsule

Prescription Status
Prescription medicine

Brand Name
CRIZALK

Pack Size
6 strips of 10 capsules each

Usage Instruction
For oral use only as directed by physician

CRIZALK CAPSULES Trade Information

Minimum Order Quantity
1 Box

FOB Port
INDIA

Payment Terms
Paypal, Cash Advance (CA), Cash in Advance (CID), Delivery Point (DP), Letter of Credit (L/C), Cheque, Days after Acceptance (DA), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union

Supply Ability
10 Boxes Per Month

Delivery Time
3 Days

Sample Available
No

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
BOX

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

Certifications
GMP COA INVOICE

About CRIZALK CAPSULES

Introduction to Crizalk 250mg Capsule

Crizalk 250mg capsule contains the active substance Crizotinib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. This medicine is prescribed to treat patients with a type of lung cancer called Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic (spread outside the lungs or to other parts of the body). Do not take Crizalk 250mg if you are allergic to Crizotinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have had kidney, stomach, heart, or liver problems.

Notify your doctor if you have reduced white blood cells, abnormal heart tracing after ECG, vision problems, or if you take other medications. Report your doctor immediately if you are planning to get pregnant or think you may be pregnant. Talk to your doctor about effective contraceptives. Use effective birth control during the treatment because oral contraception is ineffective with this medicine, and use it at least for 90 days even after completing the therapy with Crizalk 250. It is advised to get suggestions about fertility concerns from your doctor. This medication is not recommended for adolescents and children under 18 years of age. Use sunscreen or protective clothing to cover the skin and protect it against sunburn.

Precise Targeted Therapy for Lung Cancer

CRIZALK Capsules employ Crizotinib, a targeted therapy specifically for adults diagnosed with certain types of non-small cell lung cancer (NSCLC). This innovative approach aims to selectively inhibit cancer cell growth, providing a more tailored anti-cancer treatment and potentially reducing adverse effects typically associated with traditional chemotherapy.

Simple Oral Administration

Designed for ease of use, CRIZALK is administered orally. Strictly follow your physician's instructions regarding dosage and timing. The user-friendly capsule form eliminates the need for injections or hospital visits, allowing patients to continue treatment at home as part of their daily routine.

FAQ's of CRIZALK CAPSULES:

Q: How should CRIZALK Capsules be taken for best results?

A: Take CRIZALK Capsules orally, strictly following the physician's prescribed dosage and schedule. Swallow the capsules whole with water without crushing or chewing, and adhere to additional usage instructions provided by your healthcare professional.

Q: What is the main benefit of using CRIZALK for non-small cell lung cancer?

A: CRIZALK provides targeted therapy, focusing on specific cancer cells in adults with NSCLC, which can potentially result in a more effective and tailored treatment while minimizing harm to healthy cells.

Q: When should CRIZALK Capsules be taken during the course of treatment?

A: Your physician will determine the appropriate timing and duration of your treatment with CRIZALK. It is important to take the medication at the same time each day, as directed, to maintain consistent therapeutic levels.

Q: Where should CRIZALK Capsules be stored to maintain their efficacy?

A: Store the capsules in a cool, dry place, away from direct sunlight and moisture. Check the packaging for the expiry date, and keep the medicine out of reach of children.

Q: What is the process to obtain CRIZALK Capsules?

A: CRIZALK is a prescription-only medication. It can only be obtained after your doctor prescribes it, and should be purchased from a licensed pharmacy, distributor, or supplier.

Q: Who should use CRIZALK Capsules?

A: These capsules are intended for adult patients diagnosed with certain types of non-small cell lung cancer (NSCLC), as assessed and recommended by a healthcare professional.

Q: Are there any specific instructions regarding the appearance or handling of CRIZALK Capsules?

A: Although the specific capsule color is not specified, always check the packaging for authenticity and storage instructions. Do not use capsules past the expiry date, or if the packaging appears damaged.

Tell us about your requirement